Phospho-JAK2 (Y1007 + Y1008) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Phospho-JAK2 (Y1007 + Y1008) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPhospho-JAK2 (Y1007 + Y1008)
Clonemonoclonal
Host SpeciesRabbit
Reactive Specieshuman
IsotypeIgG
Formataffinity purified
Size0.05 mL, 0.1 mL
Concentrationn/a
ApplicationsELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionNon-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins (PubMed:7615558). Following ligand-binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins (PubMed:9618263). Subsequently, phosphorylat
ImmunogenImmunogen: A synthesized peptide derived from human Phospho-JAK2 (Y1007 Y1008)
Other Names[Tyrosine-protein kinase JAK2; Janus kinase 2; JAK-2; JAK2]
Gene, Accession #[JAK2], Gene ID: 3717, NCBI: NP_001309123.1, UniProt: O60674
Catalog #MBS7114853
Price$185, $265
Order / More InfoPhospho-JAK2 (Y1007 + Y1008) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.